Results 11 to 20 of about 109,191 (186)

Treatment of Recurrent or Metastatic Uterine Adenosarcoma. [PDF]

open access: yesSarcoma, 2017
Purpose. This study retrospectively evaluated overall survival (OS) by treatment of recurrent or metastatic uterine adenosarcoma including surgery, radiation, chemotherapy, and hormonal therapy and evaluated OS and progression-free survival (PFS) after 1st line systemic chemotherapy.Methods.
Nathenson MJ   +4 more
europepmc   +6 more sources

Prognostic factors in uterine adenosarcoma: subanalysis of the SARCUT study. [PDF]

open access: yesFront Oncol
ObjectiveThe purpose of the study was to analyse the role of prognostic factors on the risk of recurrence and overall survival of patients with uterine adenosarcoma.MethodsA retrospective international multicentre study involving 46 centres collected 32 ...
Mancari R   +8 more
europepmc   +4 more sources

Clinical management of uterine cervical mullerian adenosarcoma: A clinicopathological study of six cases and review of the literature

open access: yesTaiwanese Journal of Obstetrics and Gynecology, 2018
Objective: To assess the clinicopathological characteristics and clinical management of patients diagnosed with mullerian adenosarcoma of the uterine cervix.
Mika Fukuda   +2 more
exaly   +4 more sources

Uterine Adenosarcoma [PDF]

open access: yesArchives of Pathology & Laboratory Medicine, 2016
Müllerian adenosarcoma is an uncommon biphasic tumor composed of malignant stromal and benign epithelial components. Morphologically, adenosarcoma is characterized by a broad leaflike architecture, reminiscent of phyllodes tumors of the breast.
Andre, Pinto, Brooke, Howitt
openaire   +3 more sources

Metastasizing uterine mullerian adenosarcoma in a young female: Diagnostic enigma

open access: yesIndian Journal of Pathology and Microbiology, 2018
Uterine adenosarcomas are uncommon tumors. It is a biphasic tumor with both epithelial and mesenchymal component. The epithelial component is benign in nature, and the mesenchymal component is malignant. Metastasis is rare in adenosarcoma.
Rashmi Patnayak   +6 more
doaj   +2 more sources

Uterine primitive neuroectodermal tumor with adenosarcoma: a case report [PDF]

open access: yesJournal of Medical Case Reports, 2010
Introduction Primitive neuroectodermal tumor of the uterus is extremely rare. They occur as either pure primitive neuroectodermal tumors or admixed with neoplasms of mullerian origin.
Chawla Indu   +3 more
doaj   +3 more sources

Uterine Adenosarcoma: A Retrospective 12-Year Single-Center Study. [PDF]

open access: yesFront Oncol, 2019
Synopsis: Lymphovascular space invasion is an independent risk factor for disease progression and presence of tumor stalk an independent protective factor.
Yuan Z   +7 more
europepmc   +2 more sources

Development and Validation of a Personalized Survival Prediction Model for Uterine Adenosarcoma: A Population-Based Deep Learning Study. [PDF]

open access: yesFront Oncol, 2020
BackgroundThe aim was to develop a personalized survival prediction deep learning model for adenosarcoma patients using the surveillance, epidemiology and end results (SEER) database.MethodsA total of 797 uterine adenosarcoma patients were enrolled in ...
Qu W   +7 more
europepmc   +2 more sources

Non-puerperal uterine inversion associated with adenosarcoma of the uterus: A case report

open access: yesCase Reports in Women's Health, 2019
Introduction: Uterine inversion is an uncommon condition characterized by the invagination of the fundus of the uterus through the vagina and is extremely rare in non-pregnancy settings.
Alaa Eddin K. Salameh   +5 more
doaj   +2 more sources

A Case of Adenosarcoma of the Uterus

open access: yesCase Reports in Obstetrics and Gynecology, 2014
Adenosarcoma is a rare tumor which consists of benign glandular epithelium and malignant mesenchymal component. Here we report a case of adenosarcoma of the uterine corpus. Case Presentation.
Shigeki Taga   +4 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy